Prosecution Insights
Last updated: July 17, 2026
Application No. 17/503,581

CONJUGATES OF AUXIN ANALOGS

Final Rejection §112
Filed
Oct 18, 2021
Priority
Apr 18, 2019 — IL 266136 +2 more
Examiner
FAY, ZOHREH ALEMZADEH
Art Unit
1617
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
OA Round
4 (Final)
52%
Grant Probability
Moderate
5-6
OA Rounds
0m
Est. Remaining
46%
With Interview

Examiner Intelligence

Grants 52% of resolved cases
52%
Career Allowance Rate
580 granted / 1116 resolved
-8.0% vs TC avg
Minimal -6% lift
Without
With
+-6.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
49 currently pending
Career history
1179
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
68.3%
+28.3% vs TC avg
§102
7.2%
-32.8% vs TC avg
§112
5.6%
-34.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1116 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim 1, 24 and 30 are presented for examination. Claims 8-23 and 25-29 are withdrawn from examination. The amendments and remarks filed on 05/28/2026 have been received and entered. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 1 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 is indefinite as to the terms “4-CPA”, “MCPA”, “CPB”, “DB” and “TP”. Such terms fail to set forth the intended meaning. Claims 24 and 30, which are dependent on claim 1 are also rejected, since they have all the limitations of claim 1. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ZOHREH A FAY whose telephone number is (703)756-1800. The examiner can normally be reached Monday-Friday 9:30AM-6:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sue Liu can be reached at 571-272-5539. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ZOHREH A FAY/Primary Examiner, Art Unit 1617
Read full office action

Prosecution Timeline

Show 1 earlier event
Jan 30, 2025
Non-Final Rejection mailed — §112
Apr 29, 2025
Response Filed
Aug 05, 2025
Final Rejection mailed — §112
Dec 04, 2025
Request for Continued Examination
Dec 07, 2025
Response after Non-Final Action
Dec 29, 2025
Non-Final Rejection mailed — §112
Mar 20, 2026
Response Filed
Jun 17, 2026
Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12661372
A PHARMACEUTICAL COMPOSITION COMPRISING POLOXAMER 188 FOR IMPROVING THE FILTERING FUNCTION OF KIDNEYS
2y 4m to grant Granted Jun 23, 2026
Patent 12655138
PROCESS FOR MAKING AN ISOXAZOLINE COMPOUND AND INTERMEDIATE THEREOF
3y 4m to grant Granted Jun 16, 2026
Patent 12616654
STAINLESS STEEL CAN FOR PRESSURISED METERED DOSE INHALERS
3y 12m to grant Granted May 05, 2026
Patent 12616652
LENSES FOR TREATING OCULAR DISEASES AND PREPARATION METHOD THEREOF
3y 4m to grant Granted May 05, 2026
Patent 12599139
Means and Methods for Improving Plant Growth and Yield
4y 8m to grant Granted Apr 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
52%
Grant Probability
46%
With Interview (-6.4%)
3y 3m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 1116 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month